Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Orthopedic Laboratory, Chongqing Medical University, Chongqing 400016, China.
Cells. 2022 Nov 5;11(21):3508. doi: 10.3390/cells11213508.
Intervertebral disc degeneration (IVDD) is a common pathological condition responsible for lower back pain, which can significantly increase economic and social burdens. Although considerable efforts have been made to identify potential mechanisms of disc degeneration, the treatment of IVDD is not satisfactory. Ferroptosis, a recently reported form of regulated cell death (RCD), is characterized by iron-dependent lipid peroxidation and has been demonstrated to be responsible for a variety of degenerative diseases. Accumulating evidence suggests that ferroptosis is implicated in IVDD by decreasing viability and increasing extracellular matrix degradation of nucleus pulposus cells, annulus fibrosus cells, or endplate chondrocytes. In this review, we summarize the literature regarding ferroptosis of intervertebral disc cells and discuss its molecular pathways and biomarkers for treating IVDD. Importantly, ferroptosis is verified as a promising therapeutic target for IVDD.
椎间盘退行性变(IVDD)是一种常见的病理状态,可导致下腰痛,从而显著增加经济和社会负担。尽管已经做出了相当大的努力来确定椎间盘退行性变的潜在机制,但 IVDD 的治疗效果并不令人满意。铁死亡是一种新报道的细胞死亡形式(RCD),其特征是铁依赖性脂质过氧化,并已被证明与多种退行性疾病有关。越来越多的证据表明,铁死亡通过降低核髓核细胞、纤维环细胞或终板软骨细胞的活力和增加细胞外基质降解来参与 IVDD。在这篇综述中,我们总结了关于椎间盘细胞铁死亡的文献,并讨论了其分子途径和生物标志物在治疗 IVDD 中的应用。重要的是,铁死亡已被验证为 IVDD 的一个有前途的治疗靶点。